Shares in Bayer up 6.3% in premarket on report about possible glyphosate settlement

Shares in Bayer were up 6.3% in premarket trade at broker Lang & Schwarz on Friday, driven by a report on a possible out of court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News